Evidence map›Paper›PMID 14679174›Full record

ReviewThe Journal of clinical investigation2003

It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

David H Viskochil

Open access · bronzeAbstract readCommentReview
In one paragraph

Review in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. An Unusual Intraosseous Swelling of the Jaw: Two Rare Case Reports.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  2. Article
  3. AfterNeuro-oncology advances · 2020
    Review
  4. Review
  5. The plexiform neurofibroma microenvironment.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2012
    Article
  6. Article
  7. Article
  8. Article
  9. Ulcerative colitis and neurofibromatosis type 1 with bilateral psoas muscle neurofibromas: a case report.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2009
    Article
  10. Neuro-oncology of Neurofibromatosis Type 1.Current treatment options in neurology · 2009
    Article
  11. Article
  12. Article
  13. Midline cutaneous lumbosacral lesions: not always a sign of occult spinal dysraphism.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2006
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

David H ViskochilDepartment of Pediatrics, School of Medicine, University of Utah, Salt Lake City, Utah 84112, USA. DAVE.VISKOCHIL@hsc.utah.edu
University of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromas are benign tumors comprised primarily of Schwann cells and fibroblasts. Mast cell infiltration is a well-known phenomenon; however, their role in tumor pathogenesis has been enigmatic. In an elegant set of experiments using cells derived from a murine model of neurofibromatosis 1 (NF1), Yang et al. dissect the molecular pathways involved in mast cell migration to neurofibromin-deficient Schwann cells. These results set the stage for rational development of therapeutics that could influence the multicellular microenvironment of neurofibromas to inhibit the development and/or progression of these tumors in human NF1.

Indexed as

AllelesAnimalsDisease ProgressionFibroblastsHumansMast CellsMiceMice, TransgenicModels, BiologicalMutationNeoplasmsNeurofibromaNeurofibromin 1Schwann CellsSignal TransductionStem Cell FactorNeurofibromin 1Stem Cell Factor

Identifiers

PMID14679174
PMCPMC297005
OpenAlexW2031651726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.